BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26759658)

  • 1. The Changing Use of Intravenous Opioids in an Emergency Department.
    Sutter ME; Wintemute GJ; Clarke SO; Roche BM; Chenoweth JA; Gutierrez R; Albertson TE
    West J Emerg Med; 2015 Dec; 16(7):1079-83. PubMed ID: 26759658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Response in Emergency Department Patients Receiving Intravenous Opioids for Severe Pain.
    Radcliff JA; Rafeq RM; Bowen JF; Pontiggia L; Sen S
    Pharmacotherapy; 2017 Jul; 37(7):799-805. PubMed ID: 28500651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid analgesia on the battlefield: a retrospective review of data from Operation HERRICK.
    Lewis P; Wright C; Hooper C
    J R Army Med Corps; 2018 Sep; 164(5):328-331. PubMed ID: 29626143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous opioid dosing and outcomes in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Am J Emerg Med; 2010 Nov; 28(9):1041-1050.e6. PubMed ID: 20825766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: a retrospective review.
    Rebel A; Sloan P; Andrykowski M
    J Opioid Manag; 2009; 5(6):331-9. PubMed ID: 20073407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception and Practice Among Emergency Medicine Health Care Providers Regarding Discharging Patients After Opioid Administration.
    Surmaitis RM; Amaducci A; Henry K; Jong M; Kiernan EA; Kincaid H; Houck LJ; Sabbatini SJ; Greenberg MR; Katz KD
    Clin Ther; 2018 Feb; 40(2):214-223.e5. PubMed ID: 29371005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practices and perceptions regarding intravenous opioid infusion and cancer pain management.
    Arthur JA; Reddy A; Smith U; Hui D; Park M; Liu D; Vaughan-Adams N; Haider A; Williams J; Bruera E
    Cancer; 2019 Nov; 125(21):3882-3889. PubMed ID: 31291011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why do emergency providers choose one opioid over another? A prospective cohort analysis.
    O'Connor AB; Rao A
    J Opioid Manag; 2012; 8(6):403-13. PubMed ID: 23264318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario.
    Guan Q; Khuu W; Martins D; Tadrous M; Chiu M; Do MT; Gomes T
    Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):256-262. PubMed ID: 29911823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between fentanyl treatment for acute pain in the emergency department and opioid use two weeks after discharge.
    Daoust R; Paquet J; Huard V; Chauny JM; Lavigne G; Williamson D; Choinière M; Lang E; Yan JW; Perry JJ; Emond M; Gosselin S; Cournoyer A;
    Am J Emerg Med; 2022 Feb; 52():137-142. PubMed ID: 34922233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain.
    Chang AK; Bijur PE; Davitt M; Gallagher EJ
    Ann Emerg Med; 2009 Oct; 54(4):561-567.e2. PubMed ID: 19560838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing opioid waste, cost, and opportunity for drug diversion in the emergency department.
    Coleska A; Oh A; Rothenberg C; Dinh D; Parwani V; Venkatesh AK
    Am J Emerg Med; 2023 Jul; 69():195-199. PubMed ID: 37172559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients.
    Bijur PE; Schechter C; Esses D; Chang AK; Gallagher EJ
    J Pain; 2006 Feb; 7(2):75-81. PubMed ID: 16459272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Put It in the Air? Nebulized Opioids in the Emergency Department.
    Bailey AM; Weant KA
    Adv Emerg Nurs J; 2023 Oct-Dec 01; 45(4):260-269. PubMed ID: 37885077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial of an intravenous hydromorphone titration protocol versus usual care for management of acute pain in older emergency department patients.
    Chang AK; Bijur PE; Davitt M; Gallagher EJ
    Drugs Aging; 2013 Sep; 30(9):747-54. PubMed ID: 23846749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids for cancer pain - an overview of Cochrane reviews.
    Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
    Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
    J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.